This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Objective This study aimed to investigate the association between heartfailure (HF) severity measured based on brain natriuretic peptide (BNP) levels and future bleeding events after percutaneous coronary intervention (PCI). The secondary outcome was major adverse cardiovascular events (MACE).
Atrial fibrillation (AF) is a common reversible cause of worsening left ventricular ejection fraction (LVEF) in patients with heartfailure. Guidelines propose a class 1 recommendation for AF catheter ablation (CA) in patients with heartfailure with reduced ejection fraction1,2.
BACKGROUND:The absence of practice standards in vasoactive agent usage for acute decompensated heartfailure has resulted in significant treatment variability across hospitals, potentially affecting patient outcomes. in 2013 to 48.6% in 2013 to 25.8% in 2021 (Ptrend<0.001). to 77.8%.
Associations of colchicine-related plasma proteins, incident heartfailure (HF) and cardiac structure and function. HFpEF, heartfailure with preserved ejection fraction; HFrEF, heartfailure with reduced ejection fraction.
AHF, acute heartfailure; eGFR, estimated glomerular filtration rate; HCTZ, hydrochlorothiazide. Aims In patients with acute heartfailure (AHF), the addition of hydrochlorothiazide (HCTZ) to furosemide improved diuretic response in the CLOROTIC trial. Results of the CLOROTIC trial according to glomerular filtration rate.
Secondary outcomes included rates of reoperation, infective endocarditis, stroke, and hospital admissions for heartfailure. From a pool of 37,011 patients, the study identified 2,360 patients under the age of 60 years who underwent these procedures, with 22% receiving TAVR and 78% SAVR. years after TAVR and 4.9 for SAVR vs. 0.4%
The co-occurrence of keywords has generated 8 clusters, including DCM, lamin a/c, heartfailure, sudden cardiac death, hypertrophic cardiomyopathy, cardiac hypertrophy, arrhythmogenic cardiomyopathy, and next-generation sequencing.
Methods We retrospectively analysed data from 745 consecutive patients who underwent TAVI for severe aortic stenosis from November 2013 to July 2022. Freedom from rehospitalisation due to heartfailure rate was significantly higher in the PPMI (–) group (p=0.032). vs 9.1%±9.7%; p=0.035).
In multivariable analyses, the risk of 1-year heartfailure readmission for ventricular functional MR was not higher than for DMR (P=0.10642), while patients with chronic ischemic MR and atrial MR had a 19% higher risk of 1-year heartfailure readmission compared with DMR (P=0.00493) even if they had a successful procedure.
About AFib, AI and Clinical Trials from HRS 2024 The American Heart Association defines AFib as a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heartfailure, and other heart-related complications. Am J Cardiol 2013; 112:1142–1147. adult population. DOI: 10.1016/j.amjcard.2013.05.063
BackgroundData on the risk of cardiovascular‐related mortality in patients with cancer are limited.Methods and ResultsThis retrospective cohort study used data from the Osaka Cancer Registry and vital statistics in Japan between 1985 and 2013. The causes of death were investigated, and the risk of fatal heart disease was analyzed.
Current smoker, hypertension, heartfailure, previous myocardial infarction, cerebrovascular disease, CysC, and NT-proBNP were selected as independent risk factors for AKI. The risk prediction model was evaluated using receiver operating characteristic (ROC), calibration curve, and decision curve analysis (DCA).Results220
Treatment groups included the surgery group and the catheter intervention (PCI) group for CHD or coronary revascularization and an ‘others’ group (patients treated for heartfailure, infectious endocarditis or brain abscess), excluding those in the other two groups.
Coronary Heart Disease : Initiate beta-blockers in patients with acute MI and normal LVEF unless contraindicated or if they have heartfailure. HeartFailure : Home-based cardiac rehabilitation is as effective as center-based programs.
Patients in the aficamten group with LVEF less than 50% did not need interruption of treatment or have exacerbation of heartfailure, indicating the shallow dose-response relationship [2]. 2013 Jun 18;61(24):2456-2460. Epub 2013 Apr 16. PMID: 37526885. Geske JB, McKie PM, Ommen SR, Sorajja P. J Am Coll Cardiol.
The REVIVED-BCIS2 trial concluded that PCI did not reduce the incidence of all-cause death or heartfailure (HF) hospitalization, however patients assigned to PCI reported better initial health-related quality of life than those assigned to optimal medical therapy (OMT) alone. QALYs, £22,352; OMT alone: 4.16
5 [link] 6 Dementia rIsk REduCTion (DIRECT) collaboration, Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis, European Heart Journal , Volume 43, Issue 48, 21 December 2022, Pages 4980–4990 7 Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies.
Other trials that evaluated this subject were the WOEST trial (2013), Pioneer AF-PCI trial (2016), and ISAR-TRIPLE (2015). Explanation: The RE-DUAL PCI trial evaluated differences between triple therapy and dual therapy using antiplatelets/anticoagulant. These are the main aspects of the findings related to this trial.
In cardiogenic shock, fluid may worsen the pulmonary edema associated with acute heartfailure, but may still be required to support the hemodynamic status of the patient. N Engl J Med 2003; 348:1756-1763, 5/1/2013. This may be secondary to multiple factors, including decreased cardiac contractility (ie. Khot, MD; et al.
Background:Among patients with heartfailure (HF), fatigue is common and linked to quality of life and functional status. Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Fatigue is hypothesized to manifest as multiple types, with general and exertional components.
Methods All patients, registered in the Norwegian Myocardial Infarction Registry (NORMI) between 2013 and 2019 with ECG-verified AF at hospitalisation, were included in the cohort study. of 78369) patients registered in the NORMI from 2013 through 2019. Results AF was observed in 8565 (10.9% 95% CI 0.7 95% CI 0.7 p<0.001).
Methods and results Using data from AuriculA, the Swedish oral anticoagulation registry, patients with AF on warfarin or DOAC were identified between 2013 and 2018 (N=6567). Between 2013 and 2018, use of DOAC increased from 9.2% m 2 ), mild CKD (60–89 mL/min/1.73 m 2 ), moderate CKD (30–59 mL/min/1.73 m 2 )/dialysis.
In November 2023 the AHA launched the PREVENT risk equations , which take into account a wider range of cardiovascular, kidney, and metabolic health measures to estimate 10- and 30-year risks of heart attack, stroke, and heartfailure.
We sought to evaluate its incidence, risk factors, and outcomes.Methods and ResultsMedicare beneficiaries who underwent TVS from 2013 to 2020 were identified. Outcomes included all‐cause mortality and readmission with endocarditis or heartfailure on follow‐up. Patients who underwent TVS for endocarditis were excluded.
In 2013 Kellogg’s funded British research that concluded “regular consumption of cereals might help children stay slimmer.” Assessing the potential for SenseCam to fight the current global health crises of increasing obesity and physical inactivity (2010-2013) Microsoft: £69K ATLAS trial of tamoxifen duration (1997-2018) AstraZeneca: £1.0M
Incidence and Prognosis of Pericarditis After ST-Elevation Myocardial Infarction (from the Acute Coronary Syndrome Israeli Survey 2000 to 2013 Registry Database). References: [1] Lador, A. The American Journal of Cardiology , 121 (6), 690694. link] [2] Oliva, P. Hammill, S. & Edwards, W. Physical Exam was revealing.
In addition to profound acute heartfailure, the patient suffered from electrical storm. Was her outcome to be expected for ostial RCA OMI? Or was it out of proportion, perhaps worsened by the sympathetic surge? We will never know for certain. SanzRuiz, R., Solis, J., & & FernndezAvils, F. link] Bai, J.,
Methods and results Out of 2739 native AS patients, who received TAVI at the University of Cologne Heart Center between March 2013 and June 2021, 114 patients displayed pLFLG AS and were included in this study.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content